About AIM IMMUNOTECH INC.
AIM ImmunoTech is a biotechnology company focused on developing immunology-based solutions for oncology, immune disorders, and viral diseases. Their lead program, Ampligen®, is an immuno-modulator being evaluated in clinical studies for various debilitating and life-threatening conditions.
Development of immunology-based therapiesClinical evaluation of Ampligen® for oncology, immune disorders, and viral diseasesIn-vitro and animal testing of therapeutic candidates
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to AIM IMMUNOTECH INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.